BRIEF-Geron provides updates to imetelstat clinical development By: Reuters: Company News July 31, 2017 at 20:04 PM EDT * Expects imbark protocol-specified primary analysis to begin no later than q3 of 2018 Source text for Eikon: Further company coverage: Read More >> Related Stocks: Geron Corp